Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
ItalyStudy on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
ItalyStudy of CVN424 for Reducing Motor Complications in Parkinson's Disease Patients
ItalyStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
ItalyStudy of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion
ItalyStudy on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
ItalyStudy on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment
ItalyStudy on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)
ItalyStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
ItalyStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
ItalyTitle: Study of solrikitug compared to placebo for adults with Eosinophilic Esophagitis to evaluate its effectiveness and safety
ItalyStudy on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
